ORBi: Detailled Reference

Article (Scientific journals)

Quelle cible tensionnelle idéale pour nos patients hypertendus en 2010?

Krzesinski, Jean-Marie; Saint-Remy, Annie

2010 • In Revue Médicale Suisse, 6, p. 1574-1581

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/68553

PubMed
20853711

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2010 Rev Med Suisse sept 1574-001.pdf

Publisher postprint (8.37 MB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

hypertension artérielle; cible tensionnelle; risque cardiovasculaire; sujet âgé; diabète; hypertension; blood pressure goal; cardiovascular risk

Abstract :

[fr] Les directives du traitement de l'hypertension artérielle de 2007 ont été rediscutées en 2009. Quelle que soit la pathologie associée à l'hypertension artérielle, la cible à atteindre est : 130 à 139 mmHg pour la systolique et 80 à 85 mmHg pour la diastolique. Si le patient peut tolérer une pression plus basse, on ne freinera pas l’abaissement de pression. Beaucoup de questions restent cependant encore sans réelles réponses quant à des cibles plus basses en fonction de l’âge et de situations pathologiques individuelles. Le choix des agents antihypertenseurs devient primordial lors d’un risque cardiovasculaire majeur. Il convient toujours d’appliquer des règles hygiéno-diététiques à l’ensemble de la population hypertendue et d’agir sur tous les facteurs de risque associés.

Disciplines :

Urology & nephrology

Author, co-author :

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Néphrologie

Saint-Remy, Annie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

French

Title :

Quelle cible tensionnelle idéale pour nos patients hypertendus en 2010?

Alternative titles :

[en] What is the ideal blood pressure goal for the hypertensive population in 2010?

Publication date :

01 September 2010

Journal title :

Revue Médicale Suisse

ISSN :

1660-9379

Publisher :

Medecine et Hygiène, Switzerland

Volume :

6

Pages :

1574-1581

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 12 August 2010

Statistics

Number of views

118 (5 by ULiège)

Number of downloads

284 (1 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

Bibliography

Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S., Murray, C.J.L., Selected major risk factors and global and regional burden of disease (2002) Lancet, 360 (9343), pp. 1347-1360. , DOI 10.1016/S0140-6736(02)11403-6
Collins, R., Peto, R., MacMahon, Blood pressure, stroke, and coronary heart disease (1990) Lancet, 335, pp. 827-838
Franklin, S.S., Larson, M.G., Khan, Sa., Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study (2001) Circulation, 103, pp. 1245-1249
Williams, B., Lindholm, L., Sever, P., Systolic pressure is all that matters (2008) Lancet, 371, pp. 2219-2221
Mancia, G., De Backer, G., Dominiczak, A., 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology (2007) J Hypertens, 25, pp. 1105-1187
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies (2002) Lancet, 360, pp. 1903-1913. , Prospective Studies Collaboration
Arguedas, J.A., Perez, M.I., Wright, J.M., Treatment blood pressure targets for hypertension (2009) The Cochrane Library, (3), pp. 1-39. , The Cochrane collaboration. (Review)
Zanchetti, A., Grassi, G., Mancia, G., When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical appraisal (2009) J Hypertens, 27, pp. 923-934
Mancia, G., Laurent, S., Agabiti-Rosei, E., Reappraisal of European guidelines on hypertension management: A European Society of Hypertension task force document (2009) J Hypertens, 27, pp. 2121-2158
Verdecchia, P., Staessen, J., Angeli, F., Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): An open-label randomised trial (2009) Lancet, 374, pp. 525-533
Effects of intensive blood-pressure control in type 2 diabetes mellitus (2010) N Engl J Med, 362, pp. 1575-1585. , The ACCORD Study Group
Beckett, N., Peters, R., Fletcher, A., Treatment of hypertension in patients 80 years of age or older (2008) N Engl J Med, 358, pp. 1887-1898
Messerli, F., Mancia, G., Conti, R., Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? (2006) Ann Intern Med, 144, pp. 884-893
Cruickshank, J., Thorp, J., Zacharias, F.J., Benefits and potential harm of lowering high blood pressure (1987) Lancet, 1, pp. 581-584
Messerli, F., Panjarth, G., The J-curve between blood pressure and coronary artery disease or essential hypertension (2009) J Am Coll Cardiol, 54, pp. 1827-1834
Sleight, P., Redon, J., Verdecchia, P., Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study (2009) J Hypertens, 27, pp. 1360-1369
Schrier, R.W., Estacio, R.O., Mehler, P.S., Hiatt, W.R., Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: A summary of the ABCD trial (2007) Nature Clinical Practice Nephrology, 3 (8), pp. 428-438. , DOI 10.1038/ncpneph0559, PII NCPNEPH0559
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial (2007) Lancet, 370, pp. 829-840. , ADVANCE Collaborative Group
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 (1998) BMJ, 317, pp. 703-713. , UK Prospective diabetes Study Group
Scheen, A.J., Paquot, N., Approche multirisques du patient diabétique de type 2: Désaccord sur les valeurscible suite à l'étude ACCORD (2010) Rev Med Suisse, 6, pp. 1582-1587
Chobanian, A., The hypertension paradox - More uncontrolled disease despite improved therapy (2009) N Engl J Med, 361, pp. 878-887
Niiranen, T., Hänninen, M.R., Johansson, J., Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure. The Finn-Home study (2010) Hypertension, 55, pp. 1346-1351
Staessen, J., Gasowski, J., Wang, J.G., Risk of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcomes trials (2000) Lancet, 355, pp. 865-872
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (1991) JAMA, 265, pp. 3255-3264. , SHEP Cooperative Research group
Wang, J.G., Staessen, J., Francklin, S., Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome (2005) Hypertension, 45, pp. 907-913
Lindholm, L.H., Dahlöf, B., Devereux, R.B., Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol (2002) Lancet, 359, pp. 1004-1010
Dahlöf, B., Sever, P.S., Poulter, N.R., Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial (2005) Lancet, 366, pp. 895-906
Jamerson, K., Weber, M., Bakris, G., Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients (2008) N Engl J Med, 359, pp. 2417-2428
Yusuf, S., Diener, H.C., Sacco, R., Telmisartan to prevent recurrent stroke and cardiovascular events (2008) N Engl J Med, 359, pp. 1225-1237

Similar publications